The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: Still a long way to go

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 7, 2011, Pages 467-475

  Lapolla, A ^a   Mosca, A ^b   Fedele, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Diabetes; Diagnosis; HbA1c; Standardisation

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEALTH; HUMAN; PRACTICE GUIDELINE; REPRODUCIBILITY; SHORT SURVEY;

BLOOD GLUCOSE; DIABETES MELLITUS; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS; WORLD HEALTH;

EID: 79959524655     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.02.006     Document Type: Short Survey

References (75)

1. Rahbar S. An abnormal haemoglobin in red cells of diabetes. Clin Chim Acta 1968, 22:296-298.
2. Schnek A., Schroder W. The relation between the minor components of whole normal human adult haemoglobin as isolated by chromatography and starch block electrophoresis. J Am Chem Soc 1961, 83:1472-1478.
3. Gabbay K. Glycosylated haemoglobin and long-term blood glucose control in diabetes mellitus. J Clin Endocrinol Metab 1977, 44:859-864.
4. Boronat M., Saavedra P., Varillas V.F., Nòvoa F.J. Use of confirmatory factor analysis for the identification of new components of the metabolic syndrome: the role of plasminogen activator inhibitor-1 and haemoglobin A1c. NMCD 2009, 19:271-276.
5. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. DCCT Research Group.
6. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
7. Standards of medical care in diabetes 2010. Diabetes Care 2010, 33(Suppl. 1):62-69. American Diabetes Association.
8. AMD, Sid, Diabete Italia. Standard Italiani per la cura del diabete mellito. Linee guida e raccomandazioni. Infomedica Ed, 2009-2010.
9. International Diabetes Federation. Global Guideline for type 2 diabetes. 2005.
10. Ceriello A., Colagiuri S., Gerich J., Tuomilehto J. Guideline for management of postmeal glucose. NMCD 2008, 18:S17-S33.
11. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
12. Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., Engelau M.M., et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Survey 1999-2002. Diabetes Care 2006, 29:1263-1268.
13. Harris M.I. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993, 16:642-652.
14. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009, 33:1327-1334. The International Expert Committee.
15. Ollerton R.L., Playe R., Ahmed K., Dunstan F.D., Luzio S.D., Owens D.R. Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects. Diabetes Care 1999, 22:394-398.
16. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonald J.M., Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002, 48:436-472.
17. Selvin E., Craniceanu C., Brancati F., Coresh J. Short term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007, 167:1545-1551.
18. Bruns D.E., Knowler W.C. Stabilization of glucose in blood samples: why it matters. Clin Chem 2009, 55:850-852.
19. Gambino R. Glucose: a simple molecule that is not simple to quantify. Clin Chem 2007, 53:2040-2041.
20. Little R.R., Rohlfing C.L., Tennill A.L., Connolly S., Hanson S. Effects of sample storage conditions on glycated haemoglobin measurements; evaluation of five different high performance liquid chromatography methods. Diabetes Technol Ther 2007, 9:36-42.
21. Nathan D.M., Zinman B., Cleary P.A., Backlund J.Y., Genuth S., Miller R., et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complication experience (1983-2005). Arch Intern Med 2009, 169:1307-1316. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group.
22. Holman R.R., Sanjoy K.P., Bethel M.A., Matthews D.R., Neil A.W. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589.
23. Goldstein D.E., Little R.R., Wiedmeyer H.M., England J.D., McKenzie E.M. Glycosylated haemoglobin: methodologies and clinical applications. Clin Chem 1986, 32(10b):B64-B78. Proceedings of the 9th Annual Arnold O. Beckman Conference. Diabetes Mellitus: from theory to therapy.
24. Roberts W.L., Safa-Pour S., De B.K., Rohling C.L., Weykamp C.W., Little R.R. Effects of haemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem 2005, 51:776-778.
25. Mosca A., Paleari R., Dalfrà M., Di Cianni G., Cuccuru I., Pellegrini G., et al. References Intervalsf or hemoglobin A1c in pregnant women: data from an Italian Multicenter study. Clin Chem 2006, 52:1138-1143.
26. Garde A.H., Hansen A.M., Skovgaardt L.T., Christensen J.M. Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A1c, IgA, prolactin and free testosterone in healthy women. Clin Chem 2000, 46:551-559.
27. Pani L., Korenda L., Meigs J., Driver C., Chamany S., Fax C., et al. Effect of aging on A1c levels in individuals without diabetes: evidence from the Framingham Offspring study and the national health and nutrition examination survey 2001-2004. Diabetes Care 2008, 31:1991-1996.
28. Herman W., Ma Y., Uwaifo G., Haffner S., Kahn S., Horton E., et al. Differences in A1c by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program. Diabetes Care 2007, 30:2453-2457.
29. Ziemer D.C., Kolm P., Weintraub W.S., Vaccarino V., Rhee M.K., Twombly J.G., et al. Glucose-independent, black-white differences in haemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010, 152:770-777.
30. Kera P.K., Joiner C.H., Carruthers A., Lindsell C.J., Smith E.P., Franco R.S., et al. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to haemoglobin glycation. Diabetes 2008, 57:2445-2452.
31. Delpierre G., Veiga-da-Cunha M., Vertommen D., Buysschaert M., Van Schaftingen E. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites. Diabetes Metab 2006, 32:31-39.
32. Florez J.C. A genome-wide association study of treated A1c. A genetic needle in an environmental haystack. Diabetes 2010, 59:332-334.
33. Gallagher E.J., Le Roith D., Bloomgarden Z. Review of haemoglobin A1c in the management of diabetes. J Diabetes 2009, 1:9-17.
34. Kim C., McKeever Bullard K., Herman W.H., Beckles G.L. Association between iron deficiency and A1c levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2010, 33:780-785.
35. Tarim Ö, Küçükerdorgan A., Günay Ü, Eralp Ö, Ercan I. Effects of iron deficiency anemia on haemoglobin A1c in type 1 diabetes mellitus. Pediatr Int 2002, 41:357-362.
36. Selvin E., Zhu H., Brancati F.L. Elevated A1c in adults without a history of diabetes in the U.S. Diabetes Care 2009, 32:828-833.
37. Lenters-Westra E., Slingerland R.J. Six of eight haemoglobin A1c point-of-care instruments do not meet generally analytical performance criteria. Clin Chem 2010, 56:44-52.
38. Sacks D.B. The diagnosis of diabetes is changing: how implementation of haemoglobin A1c will impact clinical laboratories. Clin Chem 2009, 55:1612-1614.
39. Mosca A., Branca M.T., Carta M., Genna M.L., Giorda C.B., Ghidelli R., et al. Recommendations for the implementation of International standardization of glycated hemoglobin in Italy. GLAD Working Group (A1c delegates WG). Clin Chem Lab Med 2010, 48:623-626.
40. Natahn D.M., Kuenen J., Borg R., Zheng H., Schoenfeld D., Heine R. for the A1c Derived Average Glucose (ADAG) Study Group. Translating the A1c assay into estimated average glucose values. Diabetes Care 2008, 31:1473-1478.
41. Borg R., Kuenen J.C., Zheng H., Nathan D.M., Heine R.J., Nerup J., et al. On behalf of the ADAG study group. Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1c-Derived Average Glucose (ADAG) study. Diabetologia 2010, 53:1608-1611.
42. Lapolla A., Fedele D., Traldi P. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes. Mass Spectrom Rev 2000, 19:279-304.
43. Giugliano D., Ceriello A., Esposito K. Glucose metabolism and hyperglicemia. Am J Clin Nutr 2008, 87(Suppl.):217S-222S.
44. Ceriello A., Quagliaro L., Catone B., Pascon R., Piazzola M., Bris B., et al. Role of hyperglycemia in nitrotyrosine postprandial generation. Diabetes Care 2002, 25:1439-1443.
45. Quagliaro L., Picone L., Assaloni R., Martinelli L., Motz E., Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of poly(ADPribose) polymerase. J Thromb Haemost 2004, 2(8):1453-1459.
46. Lapolla A., Tubaro M., Fedele D., Reitano R., Aricò N.C., Ragazzi E., et al. A matrix assisted laser desorption/ionization mass spectrometry study of the non-enzymatic glycation products of human globins in diabetes Rapid Commun. Mass Spectrom 2005, 19:162-168.
47. Lippi G., Targher G. Glycated haemoglobin (HbA1c): old dogmas, a new perspective?. Clin Chem Lab Med 2010, 48:609-614.
48. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
49. Chonchol M., Katz R., Fried L.F., Sarnak M.J., Siscovic D.S., Newman A.B., et al. Glycosylated hemoglobin and the risk of death and cardiovascular mortality in the elderly. Nutr Metab Cardiovasc Dis 2010, 20:15-21.
50. Cederberg H., Saukkonen T., Laakso M., Jokelainen J., Härkönen P., Timonen M., et al. Postchallenge glucose, HbA1c, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care 2010, [Publish ahead of print].
51. Unwin N., Shaw J., Zimmet P., Alberti G.M.M. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic Med 2002, 19:708-723.
52. Selvin E., Steffes M., Zhu H., Matsushita K., Wagenknecht L., Pankow J., et al. Glycated hemoglobin, diabetes and cardiovascular risk in nondiabetic adults. New Engl J Med 2010, 362:800-811.
53. National Glycohemoglobin Standardization Program. List of NGPS certified method (updated, March 2010) at http://http:www//ngsp.org/prog/index.html.
54. Riddle M.C., Ambrosius W.T., Brillon D.J., Buse J.B., Byington R.P., Cohen R.M., et al. For the Action to Control in Diabetes (ACCORD) Investigators. Epidemiologic relationships between A1c and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 2010, 33:983-990.
55. Droumaguer C., Balkau B., Simon D., Caces E., Tichet J., Charles M.A. Use of HbA1c in predicting progression to diabetes in French men and women data form an epidemiological study on the insulin resistance syndrome (DESIR). Diabetes Care 2006, 29:1619-1625.
56. Lorenzo C., Wagenknecht L.E., Hanley A.J.G., Rewers M.J., Karter A.J., Haffner S.M. Hemoglobin A1c between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010, [Publish ahead of print].
57. Hyvarinen M., Qiao Q., Tuomilehto J., Laatikainen T., Heine R.J., Stehouwer C.D.A., et al. Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria. Diabetes Care 2009, 32:348-354.
58. Tirosh A., Shai I., Tekes-Manova D., Israeli E., Pereg D., Shochat T., et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005, 335:1454-1462.
59. Nichols G., Hillier T.A., Brown J.B. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis. Am J Med 2008, 121:519-524.
60. Zhang X., Gregg E.W., Williamson D.F., Barker L.E., Thomas W., Bullard McK K., et al. A1c level and future risk of diabetes: a systematic review. Diabetes Care 2010, 33:1665-1673.
61. Saudek C.D., Herman W.H., Sacks D.B., Bergenstal R.M., Edelman D., Davidson M.B. A new look to screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008, 93:2447-2453.
62. Ng J.M., Dawson A.J., Cox H., Atkin S.L., Kilpatric E.S. New recommendations in diagnosis of diabetes mellitus from the Department of Health: comparing the old and new. Diabetic Med 2010, 27:244-245.
63. Van'r Riet E., Alssema M., Rijkelijkhizen J.M., Kostense P.J., Nijpels G., Dekker J.M. Relationship between A1c and glucose levels in the general Dutch population. Diabetes Care 2010, 33:61-66.
64. Kramer C.K., Araneta M.R.G., Barrett-Connor E. A1c and diabetes diagnosis: the Rancho Bernardo study. Diabetes Care 2010, 33:101-103.
65. Carson A.P., Reynolds K., Fonseca V.A., Munter P. Comparison of A1c and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010, 33:95-97.
66. Lu Z.H., Walker K.Z., O'Dea K., Sikaris K.A., Shaw J.E. A1c for screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care 2010, 33:817-819.
67. Zhou X., Pang Z., Gao W., Wang S., Zhang L., Ning F., et al. Performance of HbA1c and fasting capillary blood glucose test for screening newly diagnosed and pre-diabetes defined by OGTT in Quigdao, China. Diabetes Care 2010, 33:545-550.
68. Christensen D.L., Witte D.R., Kaduka L., Jorgensen M.E., Borch-Johnsen K., Mohan V., et al. Moving to an HbA1c based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010, 33:580-582.
69. Olson D.E., Rhee M.K., Herrick K., Ziemer D.C., Twombly J.G., Phillips L.S. Screening for diabetes and prediabetes with proposed A1c-based diagnostic criteria. Diabetes Care 2010, 33:2184-2189.
70. Jeppsson J.O., Kobold U., Barr J., Finke A., Hoelzel W., Hoshino T., et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002, 40:78-89.
71. Finke A., Kobold U., Hoelzel W., Weykamp C., Miedema K., Jeppsson J.O. Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations. Clin Chem Lab Med 1998, 36:299-308.
72. Weykamp C., John W.G., Mosca A., Hoshino T., Little R., Jeppsson J.O., et al. The IFCC reference measurement system for HbA1c: a 6-year progress report. Clin Chem 2008, 54:240-248.
73. Hoelzel W., Weykamp C., Jeppsson J.O., Miedema K., Barr J.R., Goodall I., et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004, 50:166-174.
74. Consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Diabetes Care 2007, 30:2399-2400. Consensus Statement.
75. Implementation of standardization of HbA1c measurement. Clin Chem Lab Med 2008, 46:573-574. Report.